Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma.

Andreas ViardotGeorg HessRalf C BargouNicholas J MorleyGiuseppe GrittiMaria-Elisabeth GoebelerKarim IskanderDavid CohanAlicia ZhangJanet FranklinLuke Coyle

Published in: Leukemia & lymphoma (2020)

Keyphrases

diffuse large b cell lymphoma
acute lymphoblastic leukemia
epstein barr virus
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma